The National Cardiovascular Health Program
ID: CDC-RFA-DP-23-0004 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 2/24/23 National Center for Chronic Disease Prevention and Health Promotion posted grant opportunity CDC-RFA-DP-23-0004 for The National Cardiovascular Health Program with funding of $275.0 million.
The grant will be issued under grant program 93.426 Improving the Health of Americans through Prevention and Management of Diabetes and Heart Disease and Stroke.
It is expected that 51 total grants will be made
worth between $850,000 and $2.0 million.
Timing
Posted Date
Feb. 24, 2023, 12:00 a.m. EST
Closing Date
April 25, 2023, 12:00 a.m. EDT Past Due
Closing Date Explanation
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Last Updated
Feb. 24, 2023, 8:55 a.m. EST
Version
1
Archive Date
May 25, 2023
Eligibility
Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
State governments
State governments
Additional Info
Per the program’s authorizing statute or regulation: Sec 317(a) of the Public Health Service Act [42 USC 247b] only State governments, including the District of Columbia, or their bona fide agents are eligible to apply. Local health departments are eligible to compete under a separate NOFO (The Innovative Cardiovascular Health Program), and Tribes and Tribal-serving organizations are and will continue to be funded under separate NOFOs (https://www.cdc.gov/healthytribes/index.htm). FY22 House Report language asserts the significant increases to DHDSP’s budget allocations should be directed to “support, strengthen, and expand current evidence-based initiatives at the State, local, tribal, and territorial level.” Committee language further supports a continuation of DHDSP’s current efforts and “recognizes the vital importance of addressing cardiovascular disease among women and underserved communities, communities of color, those communities with limited access to information about cardiovascular health disease, and communities at risk for delaying regular monitoring of cardiovascular health as a result of the COVID–19 pandemic. The Committee supports CDC’s efforts to improve our understanding of the outcomes and health effects of COVID–19 infection, including cardiovascular disease.” [House Committee Report 117-96, p. 89. Available at: CRPT-117hrpt96.pdf (congress.gov)]More recently, FY23 House Report language directs efforts to “support, strengthen, and expand evidence-based initiatives at the State, local, tribal, and territorial level. The Committee recognizes the vital importance of addressing cardiovascular disease among women, particularly women of color, and further recognizes that the resulting costs to the health care system of unrecognized cardiovascular disease in women can be substantially reduced with appropriate public awareness and prevention”. [FY23 House Report 117-403, p. 80. Available at:CRPT-117hrpt403.pdf (congress.gov)] FY23 Explanatory Statement asserts the agreement includes an increase to strengthen and expand evidence-based heart disease and stroke prevention activities focused on high risk populations. Applicants should refer to the funding table for specific funding amounts for each state.
Award Sizing
Ceiling
$2,000,000
Floor
$850,000
Estimated Program Funding
$275,000,000
Estimated Number of Grants
51
Contacts
Contact
Centers for Disease Control - NCCDPHP
Contact Email
Contact Phone
(770) 488-5789